Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Phase 2a Lecture Notes > Haematology > Flashcards

Haematology Flashcards

1
Q

Multiple Myeloma

A

abnormal proliferation of a single clone of plasma or lymphoplasmacytic cells leading to secretion of Ig (paraprotein), causing the dysfunction of many organs (esp kidney).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Features of multiple myeloma

A

*Accumulation of malignant plasma cells in the bone marrow leading to progressive bone marrow failure (Anaemia, neutropenia or thrombocytopenia)
*Production of a characteristic paraprotein
*Kidney failure
*Destructive bone disease + hypercalcaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Multiple myeloma- Spikey Old CRAB

A

C- Ca level (high)
R- renal impairment
A- anaemia
B- B-lytic lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Myeloma- symptoms

A

Bone pain, recurrent infections, symptoms of anaemia/ renal failure /hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Myeloma- paraprotein

A

Mono clonal product of abnormal, proliferating plasma cells, mainly IgG (55%) or IgA (20%), rarely IgM or IgD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Myeloma- investigations

A

FBC (anaemic), Serum electrophoresis, tests for clinical presentations (serum Ca, U+E- renal impairment, skeletal survey- to find lytic lesions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Serum electrophoresis (SEP)

A

Separation of proteins in blood by electrical charge, bands form with many identically charged molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Multiple myeloma- SEP investigation

A

presence of M spike (suggests paraproteins) can be a sign of a multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Monoclonal gammopathy of undetermined significance (MGUS)

A

non cancerous cause of paraprotein production, no ROTI (related organ or tissue impairment), no treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Smouldering vs Symptomatic myeloma

A

Smouldering- >diagnostic criteria for myeloma, but no ROTI
Symptomatic= >diagnostic criteria + ROTI/ amyloid
ONLY TREAT SYMPTOMATIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnostic criteria for myeloma

A

> 10% or more clonal plasma cells on bone marrow
30g/L of paraprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Myeloma- prognosis

A

With good supportive care and chemotherapy, median survival= 5 years, some surviving up to 10, young patients receiving more intensive treatment may live longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AL (primary) amyloidosis

A

Proliferation of plasma cell clone. Production of abnormal forms of Ig called “light chains” and are deposited in various tissues, causing organ dysfunction and eventually death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AL amyloidosis vs multiple myeloma

A

Both disease in which identical clones of antibody-producing cells grow rapidly.
MM- growth of abnormal cells in the bone marrow
AL (primary) amyloidosis- build up of light chains produced by the abnormal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Myeloma Bone Disease (MBD)

A

> 80% of MM patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues, and neurological deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Multiple myeloma treatment- Bisphosphonates

A

inhibit osteoclast action, help ensure normokalaemia and can help reduce skeletal events in long term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aims of myeloma treatment

A

Incurable
Reduce no myeloma cells
Reduce symptoms and complications
Improve quality and length of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Haematopoietic Stem Cell Transplants (HSCT)

A

procedure where hematopoietic stem cells of any donor and any source are given to a recipient with intention of repopulating/ replacing the hematopoietic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HSCT as treatment of blood cancers

A

Almost never first step, never offered instead of chemotherapy, control cancer 1st (using chemo/ targeted treatment), then perform HSCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Stem cell transplant- Autologous

A

Obtained from the patient, frozen prior to chemo
no risk of rejection For Myeloma and Lymphoma
No Graft versus Malignancy Effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HSCT- Graft versus Malignancy Effect

A

appears after HSCT. The graft contains donor T cells that can eliminate residual malignant cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Stem cell transplant- Allogeneic

A

Stem cells from a suitable donor
Rejection/Graft vs Host Disease unique side effects
Takes longer for immune system to recover- infections common
Blood cancers like AML, ALL, MDS that cannot be cured by chemotherapy
Immunotherapy works against Cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Donors of stem cells

A

Related (siblings have 25% of being a match)
Unrelated (volunteer, cord blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Obtaining stem cells

A

Bone marrow- requires harvest in theatre
Peripheral blood- collected by leukapheresis after giving G-CSF to mobilise stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Stem cell donation- match

A

Matching of genes at HLA locci,
all genes match= full match
most genes match = mismatch
half genes = half match (haplo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Human Leukocyte Antigen (HLA)

A

present peptides to T cells, thus allowing elimination of foreign particles and recognition of self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

HLA role in stem cell transplant

A

immune system is ‘trained’ to recognise self, based HLA molecules displayed on the cell surface. HLA typing- is critical for identifying suitable donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Complications of HSCT

A

GvHD (Graft-versus-host disease)- alloimmune reaction of the donor cells against host cells- potentially fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Graft-versus-host disease (GvHD) prevention

A

Immunosuppression- from conditioning therapy (chemo typically) and immunosuppressive drugs, however risk of opportunistic infections and viral reactivation so prophylactics given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Importance of Psychosocial evaluation for pre stem cell transplant evaluation

A

Compliance and stable long-term caregiver support critical for success of allogeneic HSCT
Important to understand patient can be at higher risk of condtions further down the line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Conditioning chemotherapy

A

Combinations of chemotherapy, radiotherapy and/or immunotherapy, using different regimens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Lymphoproliferative disorders

A

Neoplastic, clonal proliferation of lymphoid cells
“A cancer of white blood cells”
Typically affects Lymph Nodes
Can be Extranodal – Bone Marrow / Liver / Spleen / Anywhere
Includes lymphomam, myeloma and leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Epidemiology of lymphoid malignancies

A

5th most common malignancy globally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Lymphoma

A

disorders caused by malignant proliferations of lymphocytes
The accumulate in the lymph nodes, peripheral blood and infiltrate organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Classification of lymphoma

A

Lymphoma> Hodgkin’s lymphoma/ Non-Hodgkin’s lymphoma (NHL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Hodgkin’s lymphoma vs Non-Hodgkin’s lymphoma

A

Hodgkin’s lymphoma- characteristic cells with mirror image nuclei are found, called Reed-Sternberg Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Classification of Non-Hodgkin’s lymphoma

A

NHL> aggressive/ indolent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Cells affected by NHL

A

B cell- 90%
T cell- 10%
NK cell< 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Why is B cell the most common cell affected by NHL

A

B cells go through 2 processes when maturing, somatic hypermutation and class switching
Somatic hypermutation is more likely to go wrong and produce a cancerous cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Stages of NHL

A

Stage I- Lymphoma in one lymph node area or one group of lymph nodes
Stage II- Lymphoma in two or more lymph node areas, either above or below the diaphragm.
Stage III- Lymphoma found in the lymph nodes or the spleen above and below the diaphragm.
Stage IV- Lymphoma spread to the bone marrow, the bones, or to more than one organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Indolent lymphoma (low grade)

A

Slow growing and advanced at presentation
Usually Incurable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Indolent

A

causing little or no pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Richter transformation

A

CLL (type of indolent lymphoma) to more aggressive lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Indolent lymphoma- aetiology

A

Typically causes is unknown
RFs- Primary/secondary immunodeficiency, infection, autoimmune disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Indolent lymphoma- clinical signs

A

Majority present with painless lymphadenopathy
B symptoms- Fevers, Night Sweats and Weight Loss
Bone marrow involvement- leukemic component
Autoimmune Phenomena
Compression Syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Indolent lymphoma- investigation

A

Lymph Node Biopsy – Core Needle Biopsy / Excision Node Biopsy
Can do bone marrow biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Indolent lymphoma- staging

A

Lugano Staging Classification typical for most Indolent lymphomas
Requires Imaging – CT Neck/ Thorax/ Abdomen/ Pelvis or PET-CT
Bloods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Indolent lymphoma- treatment pathway

A

Watch and Wait / Active Surveillance- asymptomatic
Radiotherapy- local control
Chemoimmunotherapy +/- maintenance- depends on stage and type of lymphoma
Small molecules inhibitors / Novel therapies- more targeted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Immerging treatments for indolent lymphoma

A

Bi-Specific T-Cell engaging Antibodies
Chimeric Antigen Receptor T Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Bi-Specific T-Cell engaging Antibodies (BITE)

A

bispecific molecules are created by linking the targeting regions of two antibodies. T cell then destroyed cancerous cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Chimeric Antigen Receptor T Cells (CAR-T/NK)

A

T cells are cells that are genetically engineered in the lab. They have a new receptor so they can bind to cancer cells and kill them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Treatment of lymphoid malignancies

A

Immunochemotherapy, radiotherapy, allograft, check point inhibitors, BITE, CAR-T/NK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Check point inhibitors

A

type of immunotherapy. They block proteins that stop the immune system from attacking the cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Myelodysplastic syndromes (MDS)

A

Group of acquired bone marrow disorders that are due to a defect in stem cells, manifest as marrow failure with risk of life threating infection/ bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Myelodysplastic syndromes (MDS)- characteristics

A

Increasing bone marrow failure with quantitative and qualitative abnormalities in at least one of the 3 myeliod cell lines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

3 myeloid cell lines

A

RBC, granulocytes/ monocytes, platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Medinan age of Myelodysplastic syndromes (MDS)

A

76 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Myelodysplastic syndromes (MDS)- clinical features

A

Low blood counts- RBC (fatigue, SOB, light-headedness), WBC (increased risk of severe +/ frequent infection), platelets (bleeding/ bruising)
Peripheral blood film demonstrates dysplastic features (e.g hypogranular neutrophils, platelet, blasts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Acute myeloid leukaemia (AML)

A

Neoplastic proliferation of blast cells derived from marrow myeloid elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Blast cells

A

immature cells known as precursor or stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Acute myeloid leukaemia (AML)- incidence

A

Commonest acute leukaemia, risk incidence with age
Mean age of onset- 68 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Acute myeloid leukaemia (AML)- clinical features

A

Marrow failure- WBC- can be low, normal or high (WBC being abnormal causes symptoms)
-Low RBC (fatigue, SOB, light-headedness) and platelets (bruising/ bleeding)
Infiltration: Hepatomegaly, splenomegaly, gum hypertrophy, skin involvement.
Blast cells present on blood film

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Myelodysplastic syndromes (MDS)/ Acute myeloid leukaemia (AML) differential diagnosis

A

B12/ folate or mix haematic deficiency, infection, medications, autoimmune, liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Myelodysplastic syndromes (MDS)/ Acute myeloid leukaemia (AML) investigations

A

Review of previous blood test results
FBC (Low RBC/platelet, WBC can be high, normal or low)
Blood film- presence of blast cells
Bone marrow aspirate and trephine biopsy
Haematinic (B12, folate, ferritin)- for differential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What to do if there are blasts on peripheral blood?

A

Refer to haematologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What to do if patient has low thresholds after FBC

A

Repeat FBC in 1-2 weeks, tell to ring if they notice any new symptoms (symptomatic anaemia, infection, bleeding/ bruising)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Morphology

A

appearance of cells on slides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Myelodysplastic syndromes (MDS) morphology

A

Requirement of 10% dysplasia in any cell line
0< blast% <19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Acute myeloid leukaemia (AML) morphology

A

20%< blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Myelodysplastic syndromes (MDS) prognosis

A

Low risk- 5,5 years
High risk- 2.2 years
No MDS same as the next, disease behaviour and affects can change over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Myelodysplastic syndromes (MDS) treatment goals

A

Prolong survival, maintain good QoL (improve symptoms of low BC, delay/ supress progression to AML), minimise toxicity if treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Myelodysplastic syndromes (MDS) treatment

A

Depends on the individual, supportive treatments for low BC, immunosuppressive agents, allogenic MSCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Myelodysplastic syndromes (MDS)- Supportive treatments to improve symptoms of low blood count

A

Anaemia- RBC transfusions, reduce/ treat associated bleeding, erythropoietin
Neutropenia- antibiotics, G-CSF injections (granulocyte-colony stimulating factor- increases WBC production)
Thrombocytopenia- platelet transfusions, tranexamic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Treatment of Acute myeloid leukaemia (AML)- intensive

A

Chemotherapy + supportive measures- fertility cryopreservation transfusion of RBC, platelets, treatment for infection
Allogeneic bone marrow transplants to repopulate marow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Treatment of AML- less intensive

A

Non curative- for older/ less fit patients
Aim to improve bone marrow function and QoL
Azacytidine, low dose subcutaneous cytarabine, trail drugs + supportive measures- transfusion of RBC, platelets, treatment for infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Anaemia

A

Decrease in haemoglobin in the blood below the reference level for age and sex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Anaemia symptoms

A

can be asymptomatic
Symptoms are non specific- breathlessness, fatigue, headaches, palpitations and faintness
Can exacerbate CV problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Anaemia- clinical signs

A

Pallor, tachycardia, systolic flow murmur, cardiac failure
Specific for diff types of anaemia- koilonychia (iron deficiency), jaundice (haemolytic anaemia), bone deformities (thalassaemia major), leg ulcers (sickle cell disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Koilonychia

A

Spoon-shaped dented nails seen in longstanding iron deficiency anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

3 types of Anaemia

A

Low MCV- microcytic anaemia
Normal MCV- normocytic anaemia
High MCV- macrocytic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Is anaemia a final diagnosis?

A

No, a cause should always be sought

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Anaemia- decreased RBCs production

A

Iron/ folate/ B12 deficiency
Bone marrow failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Anaemia - increased loss of RBCs

A

Bleeding
Haemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Anaemia- FBC

A

Relevant parameters: low haemoglobin (are WBC and platelet also low), MCV (mean cell (corpuscular) volume), MCH (mean cell haemoglobin)
Specific request- reticulocyte count- no young RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Sex adjusted haemoglobin

A

Female normal= 110-147g/l
Male normal= 131-166g/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

MCV (mean cell (corpuscular) volume)

A

Cell size, normal range (normocytic)= 80-98 fl
Macrocytic- cell larger than normal > 98 fl
Microcytic- cell smaller than normal < 80 fl

87
Q

MCH (mean cell haemoglobin)

A

Amount of haemoglobin, normal range (normochromic)= 27-33pg
Hypochromic- less haemoglobin than normal < 27pg
Hyperchromic- more haemoglobin than normal > 33pg

88
Q

Would a haemoglobin level of 120 g/l be considered normal?

A

Yes for females, within normal range range of 110-147g/l
No for males, below normal range of 131-166g/l- anaemic

89
Q

Classification of anaemia by cell size- microcytic

A

TAILS- Thalassaemia (genetic low Hb),
Anaemia of chronic disease
Iron deficiency
Lead poisoning
Sideroblastic anaemia

90
Q

Thalassaemia

A

suspect if the MCV is ‘too low’ for the Hb level and the red cell count is raised, though definitive diagnosis needs DNA analysis

91
Q

Classification of anaemia by cell size- normocytic

A

High reticulocytes with increased unconj bili + reduced haptoglobin= haemolysis
High reticulocytes= blood loss
Low reticulocytes- CKD, haem malg, mixed pict, endocrine

92
Q

Classification of anaemia by cell size- normocytic + High reticulocytes with increased unconj bili + reduced haptoglobin

A

haemolysis

93
Q

Classification of anaemia by cell size- normocytic + High reticulocytes without increased unconj bili + reduced haptoglobin

A

Blood loss

94
Q

Classification of anaemia by cell size- normocytic + low reticulocytes

A

CKD, haem malg, mixed pict, endocrine

95
Q

Classification of anaemia by cell size- macrocytic

A

Megaloblasts present- Folate/ B12 deficiency
No megaloblasts- liver disease, alcohol, hypothyroidism, myelodysplasia
Other- Reticulocytotisis, cytotoxics, antifolate drugs, marrow infiltration

96
Q

Classification of anaemia by cell size- macrocytic with megaloblast present

A

b12/ folate deficiency

97
Q

Classification of anaemia by cell size- macrocytic without megaloblast present

A

liver disease, alcohol, hypothyroidism, myelodysplasia

98
Q

Normal iron metabolism

A

Normal diet- 15mg/day (~1mg absorbed/day)
Needed haemoglobin metabolism
Absorbed in duodenum/ upper jejunum

99
Q

Iron deficiency anaemia- causes

A

Assume blood loss- (gastrointestinal, menstrual)
Pregnancy (500- 1000mg transferred daily, body stores 4g)
Impaired absorption- coeliac, gastrectomy
Dietary deficiency abnormal- risk in vegans, elderly

100
Q

Iron deficiency anaemia- investigations

A

FBC- microcytic, hypochromic RBC
Fe studies:
Serum ferritin- Low ferritin diagnostic, normal/high ferritin difficult to interpret as acute phase protein
Low transferrin saturation, high total iron binding capacity

101
Q

Iron deficiency anaemia- management

A

Investigate/ treat source of blood loss (treat cause)
Replace iron; oral iron preferred (e.g. ferrous sulphate)- IV no faster than oral
Hb should rise ~2g every 3-4 weeks. .
When Hb + MCV are normal- continue supplementation for a further 3 months to replenish stores.

102
Q

Fe studies

A

Ferritin, serum iron, Transferrin, Transferrin saturation, TIBC (total iron binding capacity)

103
Q

Fe studies- ferritin

A

Measure of iron stores. Male 30-400ug/L. Female age >60 30-400ug/L. Female age 17-60 15 – 150ug/L

104
Q

Causes of increased ferritin

A

Inflammation, tissue destruction, liver disease, malignancy, iron replacement

105
Q

Fe studies- Serum Iron

A

Female- 6.6 – 26 umole/l
Male 11 – 28 umole/litre
Variation day to day and circadian
Not helpful for clinical iron status

106
Q

Fe studies- Transferrin saturation

A

Normal levels - 15-50%
Transferrin synthesis is increased in iron deficiency so as a proportion less of it is occupied by iron

107
Q

Laboratory parameters in iron metabolism- TIBC

A

Total iron binding capacity- proteins in the serum that bind iron; transferrin is principle amongst these.

108
Q

Plummer-Vinson syndrome

A

consists of a triad of dysphagia, iron deficiency anaemia, and oesophageal webs
Symptoms usually resolve by correction of anaemia

109
Q

Anaemia of chronic disease

A

Commonest anaemia in hospital patients
Many causes ie chronic infection, vasculitis, rheumatoid, malignancy, renal failure

110
Q

Anaemia of chronic disease- Fe studies

A

Ferritin- normal/ raised
Serum Fe- low
Transferrin- low
Transferrin sat- normal/ low
TIBC- Low

111
Q

Thalassaemia- Fe studies

A

Ferritin- normal/ raised
Serum Fe- normal/ raised
Transferrin- normal/ low
Transferrin sat- normal/ raised
TIBC- normal/ Low

112
Q

Thalassaemia

A

=lack of haemoglobin production
Inherited, caused mutations in alpha/ beat units, causes microcytosis, can lead to organ failure

113
Q

Transfusion-Dependent β Thalassaemia

A

Transplant only curative option
Regular blood transfusions for survival
Iron overload – heart, liver and endocrine organs
Iron chelation
Deaths due to sepsis or cardiac iron overload

114
Q

Thalassaemia- management and treatment

A

Hb electrophoresis- Hb A2, Hb H
Blood film
Treat with blood transfusions, venesection (procedure to reduce no RBS), splenectomy

115
Q

Folate- normal metabolism

A

0.1-0.2mg/day required
NOTE minimal body stores; last 3-4 months
Needed for DNA replication
Absorbed in proximal jejunum
Normal levels > 3.9ug/L

116
Q

Causes of folate deficiency (< 3.9 ug/L)

A

Poor nutrition- found in green vegetables, nuts, yeast; destroyed by cooking
malabsorption- coeliac, crohns, pregnancy, haemolysis.

117
Q

Treatment of folate deficiency

A

Replace orally
Do not replace folate without checking B12

118
Q

Why check and replace B12 before replacing folate?

A

folic acid treatment can sometimes improve your symptoms so much that it masks an underlying vitamin B12 deficiency
Untreated B12 deficiency can cause irreversible neurological damage

119
Q

B12 normal metabolism

A

Normal levels 197- 771 ng/L
Exclusively found in animal-derived products; meat, fish, eggs, dairy.
Body stores last 3 years.
Absorbed in terminal ileum; requires intrinsic factor produced by gastric parietal
Required for DNA synthesis + fatty acid synthesis

120
Q

B12 deficiency causes

A

Pernicious anaemia (autoimmune gastric atrophy; loss of intrinsic factor production)
Gastrectomy/ ileal resection
Vegan diet
bacterial overgrowth
oral contraceptives
nitric oxide- inactivates B12

121
Q

Pernicious anaemia

A

Lack of intrinsic factor production due to autoimmune gastric atrophy, leads dietary B12 remain unbound and cannot be absorbed in to the terminal ileum
Lack of vitamin B12 or folate causes the body to produce abnormally large red blood cells that cannot function properly> anaemia

122
Q

B12 deficiency clinical signs

A

Symptoms of anaemia, pallor and mild jaundice, red sore tongue and angular stomatitis
Neurological signs- Paraesthesia in extremities, early loss of vibrations sense + proprioception, progressive weakness and ataxia

123
Q

B12 deficiency- management and investigation

A

Test for intrinsic factor antibodies.
IM replacement (initially frequent, then maintenance. Consider oral replacement if strongly suspect dietary deficiency).
In combined B12 and folate deficiency ensure B12 started before folate.

124
Q

Important complication of untreated B12 deficiency

A

Can cause irreversible neurological changes
Classical neurological feature- Polyneuropathy progressively involving the peripheral nerves, posterior and then lateral columns of the spinal cord

125
Q

Haemolysis

A

Premature breakdown of RBC before their normal lifespan of 120 days

126
Q

Compensated vs decompensated haemolysis

A

Compensated haemolysis – increased destruction matched by increased synthesis
Decompensated haemolysis – rate of destruction exceeds rate of synthesis, causing anaemia

127
Q

Haemolysis investigation

A

blood film (?spherocytes- abnormal, spherical RBC, polychromasia- high no immature RBC in blood, red cell fragments?)
reticulocyte count
bilirubin, including unconjugated bilirubin,
lactate dehydrogenase
haptoglobin
direct Coombs (antiglobulin) test

128
Q

Haemolysis- causes

A

red cell membrane disorders (hereditary spherocytosis), abnormal haemoglobins (sickle cell), microangiopathic haemolytic anaemias, prosthetic heart valves, autoimmune haemolytic anaemias

129
Q

Direct Coombs test

A

Identifies RBC coated with antibody or complement, the presence of which indicates an immune cause of anaemia

130
Q

Indirect Coombs test

A

Used for prenatal testing and before blood transfusions
It detects antibodies against RBCs that are free in serum
Serum is incubated with RBCs of known antigenicity, if agglutination occurs, the test is positive

131
Q

Indirect Coombs test- positive

A

suggests Erythroblastosis fetalis (blood types of a mother and baby are incompatible), Incompatible blood match (when used for blood transfusion)

132
Q

Sickle cell disease

A

Abnormal Hb, caused by single point mutation in the beta globin gene causing HbS
Autosomal recessive
Shape change to sickle appearance when deoxygenated, initially reversible but after repeated sickling becomes irreversible

133
Q

Sickle cell disease- causes of complications

A

Blocks blood vessels – ischaemia, sequestration
Chronic haemolysis – low baseline Hb

134
Q

Sickle cell disease- complications

A

Vaso-occlusive crises, acute chest syndrome, pulmonary hypertension, anaemia, sequestration blood pools in liver and spleen, cardiac/ renal/ liver failure + many long term problems (ie growth and development, bones, infections ect)

135
Q

Sickle cell disease- diagnosis

A

Sickle solubility test
Hb electrophoresis
Antenatal: molecular genetics

136
Q

Sickle cell disease- prognosis

A

Life Expectancy: Good Care Goes a Long Way, but Early Mortality Still Persists

137
Q

Sickle cell syndrome- Acute chest syndrome

A

Lung damage, hypoxia, HbS polymerisation, reduced BF, lung damages
Exchange blood transfusion

138
Q

Preventing Sickle Cell Disease Complications

A

Supportive- warm, hydrated, vaccinations, antibiotics + monitoring
Regular blood transfusion – exchange / top up
Hydroxycarbamide - ↑ HbF (foetal Hb)
Transplant only curative therapy- genetic therapies trials currently ongoing

139
Q

Myeloproliferative neoplasms

A

Clonal stem cells disorders characterized by uncontrolled proliferation of 1 or more cell line in the bone marrow. Usually erythroid, myeloid +/ megakaryocyte lines

140
Q

Myeloproliferative neoplasms- line affected

A

Usually erythroid, myeloid +/ megakaryocyte lines

141
Q

Myeloproliferative disorders

A

Polycythaemia Vera (PV)
Essential thrombocythemia (ET)
Myelofibrosis- all 3 have JAK-2 molecular lesion
Chronic myeloid leukaemia- genetic BCR-ABL lesion

142
Q

Polycythaemia

A

increase in haemoglobin, PVC + RBC count

143
Q

Polycythaemia- primary vs secondary

A

primary – abnormality of the cells in the bone marrow that form red blood cells commonest type- polycythaemia vera
secondary – disorder originating outside of the bone marrow that causes overstimulation of the normal bone marrow, leading to an overproduction of red blood cells, ie high altitude, chronic lung disease, heavy smoking

144
Q

Polycythaemia vera (PV)

A

Malignant proliferation of a clone derived from on pluripotent stem cell. Most commonly due to mutation on the JAK2 gene

145
Q

JAK2

A

transduces signals triggered by haemopoietic growth factors

146
Q

Polycythaemia vera (PV) clinical features

A

Onset is insidious
Typically 60+, presents with tiredness, itching (after hot bath or when patient warm), vertigo, headache and visual disturbances.
May present with complications as result of thrombosis or haemorrhage

147
Q

Polycythaemia vera (PV)- diagnostic criteria

A

Major- Haemoglobin high +/ increased RBC mass +/ increased number of RBC (haematocrit >49% in men, >48% in women)
-Bone marrow tri-linage proliferation with megakaryocytes
-presence of JAK2 mutation

148
Q

Polycythaemia vera (PV)- main complications

A

Thrombosis and haemorrhage

149
Q

Polycythaemia vera (PV)- treatment

A

Aimed to maintain normal blood count and reduce risk of complications
Daily low dose aspirin
Venesection
Hydroxycarbamide
Chemo- for high risk patient with venesection not working

150
Q

Essential thrombocythemia (ET)

A

Clonal proliferation of megakaryocytes that leads to an increase in number of circulating platelets with abnormal function

151
Q

Essential thrombocythemia (ET) symptoms

A

Bleeding or arterial + venous thrombosis
Microvascular thrombosis- headache, atypical chest pain, light-headedness,

152
Q

Erythromelalgia

A

rare clinical syndrome characterized by a triad of redness, warmth, and burning pain, most notably affecting the extremities

153
Q

Essential thrombocythemia (ET) treatment

A

Daily low dose aspirin
Hydroxycarbamide in high risk paitents

154
Q

Myelofibrosis

A

Hyperplasia of megakaryocytes with produce platelet-derived growth factor, leads to intensive marrow fibrosis and haematopoiesis in liver and spleen (massive hepatosplenomegaly)

155
Q

Myelofibrosis presentation

A

Hypermetabolic symptoms- night sweats, fever, weight loss
Abdominal discomfort due to hepatosplenomegaly
Bone marrow failure- low Hb, infections, bleeding

156
Q

Myelofibrosis investigation and treatment

A

Film- Nucleated RBC, characteristic tear drop RBC
Bone marrow biopsy is diagnosis
Marrow supportive treatment
Allogeneic stem cell transplant may be curative in young people- high risk

157
Q

Chronic myeloid leukaemia (CML)

A

Uncontrolled proliferation of myeloid cells,
15% of leukaemias- occurs most often between 40-60, male predominance, rare in childhood

158
Q

Philadelphia chromosome

A

Present in >80% of CML, hybrid chromosomes when long arms 9 and 22 break off and trade places
Prognosis better when patient has CML with Philadelphia chromosome

159
Q

Chronic myeloid leukaemia (CML)- signs and symptoms

A

Weight loss, tiredness, fever, sweats, may be asymptomatic
May be features of gout (purine breakdown), bleeding (platelet dysfunction) and abdominal discomfort (splenomegaly, >75%)
Other signs- Hepatomegaly, anaemia, bruising

160
Q

Chronic myeloid leukaemia (CML)- investigation

A

Very high WBC
Low/normal Hb, platelets variable, High urate, B12
Cytogenetic analysis of bone marrow for Philadelphia chromosome

161
Q

Chronic myeloid leukaemia (CML)- treatment

A

Imatinib- CML 1st cancer when knowledge of genotype has lead to a specifically targeted drugs
Allogeneic stem cell transplant may be curative- high risk

162
Q

Classification of myeloproliferative disorders by proliferating cell type- RBC

A

Polycythaemia vera (PV)

163
Q

Classification of myeloproliferative disorders by proliferating cell type- WBC

A

Chronic myeloid leukaemia (CML)

164
Q

Classification of myeloproliferative disorders by proliferating cell type- Platelet

A

Essential thrombocythemia (ET)

165
Q

Classification of myeloproliferative disorders by proliferating cell type- Fibroblasts

A

Myelofibrosis

166
Q

Acute lymphoid leukaemia (ALL)

A

Malignancy of lymphoid cells, affecting B-/T-lymphocyte cell lineages, arresting maturation and promoting uncontrolled proliferation of immature blast cells with bone marrow failure and tissue infiltration

167
Q

Acute lymphoid leukaemia (ALL) epidemiology

A

Associated with ionising radiation during pregnancy and down’s syndrome
Commonest cancer of childhood, rare in adults

168
Q

Acute lymphoid leukaemia (ALL) classification

A

Morphological- divided in to 3 types by microscopic appearance (L1, L2, L3)
Immunological- Surface marker used to classify ALL into: Pre-cursor B-cell ALL, T-Cell ALL + B-cell ALL
Cytogenetic- chromosomal abnormalities, useful for predicting prognosis

169
Q

Acute lymphoid leukaemia (ALL) signs and symptoms

A

Due to: Bone marrow failure- anaemia (low Hb), infection (low WBC) + Bleeding (low platelet)
Infiltration- Hepato/splenomegaly, lymphadenopathy (swelling of lymph nodes), orchidomegaly (testicle enlargement)
CNS involvement- CN palsies, meningism (neck stiffness, headaches without meninge inflammation)

170
Q

Acute lymphoid leukaemia (ALL)- common infections

A

Chest, mouth, skin, perianal
Bacterial septicaemia, zoster, CMV, measles, candidiasis, Pneumocystis pneumonia

171
Q

Acute lymphoid leukaemia (ALL)- investigations

A

Characteristic blast cells on blood film and bone marrow, high WBC
CXR/CT scan for mediastinal + abdominal lymphadenopathy
Lumbar puncture- look for CNS involvement

172
Q

Acute lymphoid leukaemia (ALL)- treatment

A

Supportive- Blood/platelet infusions, IV fluids, infection management (dangerous due to neutropenia)
Chemotherapy- complex, multi-drug/phase, may take years
Allogeneic marrow transplant- best option for young adults in 1st remission

173
Q

Acute lymphoid leukaemia (ALL)- prognosis

A

Children- 70-90% curative
Adults- 40% curative
Poorer prognosis if adult, Philadelphia chromosome present, CNS signs or B-cell ALL

174
Q

Chronic lymphoid leukaemia (CLL)

A

Commonest leukaemia, more common males
Hallmark- progressive accumulation of of a malignant clone of functionally incompetent B cell

175
Q

Chronic lymphoid leukaemia (CLL) staging + median survival- Rai stage 0

A

Lymphocytosis (increase number of lymphocytes)
>13 years

176
Q

Chronic lymphoid leukaemia (CLL) staging + median survival- Rai stage 1

A

Lymphocytosis (increase number of lymphocytes) + lymphadenopathy
8 years

177
Q

Chronic lymphoid leukaemia (CLL) staging + median survival- Rai stage 2

A

Lymphocytosis (increase number of lymphocytes) + spleno- or hepatomegaly
5 years

178
Q

Chronic lymphoid leukaemia (CLL) staging + median survival- Rai stage 3

A

Lymphocytosis (increase number of lymphocytes) + anaemia
2 years

179
Q

Chronic lymphoid leukaemia (CLL) staging + median survival- Rai stage 4

A

Lymphocytosis (increase number of lymphocytes) + low platelet count
1 year

180
Q

Chronic lymphoid leukaemia (CLL) signs and symptoms

A

Often asymptomatic- present as surprise finding on RBC
May be anaemic or infection prone, or have weight loss, sweats, anorexia if severe
Enlarged, rubbery, non-tender nodes, spleno/hepatomegaly

181
Q

Chronic lymphoid leukaemia (CLL) investigations

A

FBC- Increased lymphocytes
Later- autoimmune haemolysis, marrow infiltration (low Hb/neutrophils, platelets)

182
Q

Chronic lymphoid leukaemia (CLL) complications

A

Autoimmune haemolysis
Infection due to reduced IgG, bacterial, viral (especially zoster)
Marrow failure

183
Q

Chronic lymphoid leukaemia (CLL) treatment

A

Treat if symptomatic
Chemo and monoclonal antibody therapy
Steroids for autoimmune haemolysis
Radiotherapy helps lymphadenopathy and splenomegaly
Stem cell transplantation- for some patients
Supportive care- transfusion, IV human Ig if recurrent infection

184
Q

Chronic lymphoid leukaemia (CLL) natural history

A

1/3 never progress
1/3 progress slowly
1/3 progress actively
Death often due to infection or transformation to aggressive lymphoma (Richter’s syndrome)

185
Q

Leukaemia vs Lymphoma

A

Both originate in lymphocytes
Leukaemia typically originates in bone marrow and spreads through the bloodstream
Lymphoma usually originates in lymph nodes or the spleen and spreads through the lymphatic system

186
Q

Hodgkin lymphoma

A

Malignant proliferations of lymphocytes that accumulate in the lymph nodes causing lymphadenopathy, but may also be found in peripheral blood or infiltrate organs
Characteristic cells with mirror-image nuclei known as Reed-Sternberg cells

187
Q

Hodgkin lymphoma incidence

A

2 peaks- young adults (commonest malignancy in 15-24), elderly
Affects women more commonly than men
RFs- affected sibling, EBV (Epstein-Barr virus), Systemic lupus erythematosus (SLE), post-transplant

188
Q

Hodgkin lymphoma symptoms

A

Enlarged, rubbery, non-tender nodes (60-70% cervical, can be axillary or inguinal)
Node size may fluctuate, may become matted, may be alcohol induced node pain
25% have constitutional upset- weight loss, fever, night sweats, pruritis + lethargy
Mediastinal lymph node involvement may cause local issues (SVC/bronchial obstruction, pleural effusions)

189
Q

Hodgkin lymphoma signs

A

Lymphadenopathy
Also anaemia, spleno/hepatomegaly, cachexia (weakness/ wasting due to chronic disease)

190
Q

Hodgkin lymphoma investigations + treatment

A

Tissue biopsy- Lymph node excision biopsy ideally
Bloods- increased ESR (erythrocyte sedimentation rate) / low Hb= poorer prognosis
Imaging- CXR, CT/PET scan of thorax, abdo + pelvis useful for staging

191
Q

Hodgkin lymphoma Ann Arbor staging- stage 1

A

Confined to single lymph node region

192
Q

Hodgkin lymphoma Ann Arbor staging- stage 2

A

Involvement of 2 or more lymph node region on the same side of diaphragm

193
Q

Hodgkin lymphoma Ann Arbor staging- stage 3

A

Involvement of nodes on the both sides of diaphragm

194
Q

Hodgkin lymphoma Ann Arbor staging- stage 4

A

Spread beyond lymphatic system into organs (ie liver or bone marrow)

195
Q

Hodgkin lymphoma treatment

A

Chemoradiotherapy- length of chemo depends on stage (longer course for worse spread of disease)
Relapse- high dose chemo + allogenic stem cell transplant

196
Q

Aplastic anaemia

A

Rare stem cell disorder in which bone marrow stops making cells leading to pancytopenia (deficiency of all 3 blood components; RBC, WBC, platelet)

197
Q

Aplastic anaemia presentation

A

features of anaemia (low Hb), infection (low WBC), bleeding (low platelet)

198
Q

Aplastic anaemia presentation

A

Mostly autoimmune, triggered by drugs, viruses (ie parvovirus, hepatitis), or irradiation
May be inherited

199
Q

Aplastic anaemia investigations and treatment

A

Bone marrow biopsy is diagnostic
Supportive in asymptomatic patients- blood transfusion and neutropenic regimen
Young people with severe disease- Allogeneic blood transfusion can be curative
Immunosuppression may be effective but not curative

200
Q

Glucose-6-phosphate deficiency

A

Main RBC enzyme defect
Affects 100 million (mainly women) people in the Mediterranean, Africa, Middle/far east
Avoid henna use in G6PD

201
Q

Glucose-6-phosphate deficiency symptoms

A

Most are asymptomatic
May get oxidative crises due to decreased glutathione production, precipitated by drugs (eg primaquine, sulphonamides, aspirin), exposure to Vicia faba (broad beans/favism) or illness

202
Q

Glucose-6-phosphate deficiency- oxidative crisis management

A

In attack, there is rapid jaundice + anaemia
Film- bite- + blister-cells
Test- enzyme array (>8 weeks after crisis, young RBC might have enough enzyme)

203
Q

Haemolytic anaemia- Malaria

A

RBC lysis and blackwater fever (haemoglobinuria- HB is found in abnormally high conc in urine) can cause anaemia

204
Q

Haemolytic anaemia- Alpha thalassemia

A

Genetic condition affecting alpha peptide chains of Hb- controlled 4 genes
Can cause death in utero (if all 4 genes are delete), moderate anaemia + features of haemolysis (if 3/4 genes are deleted) + asymptomatic carrier state with reduced MCV (if 2/4 are deleted)

205
Q

Haemolytic anaemia- Membranopathy- spherocytosis

A

Autosomal dominant- membrane defect
Less deformable (more rigid) spherical RBCs, so trapped in spleen> extravascular haemolysis
Splenomegaly, jaundice

206
Q

Haemolytic anaemia- Membranopathy- elliptocytosis

A

Autosomal dominant- membrane defect
Mostly asymptomatic- may protect from Malaria
10% present severe phenotype (can lead to death in utero)

207
Q

Immune Thrombocytopenia (ITP)

A

Caused by antiplatelet antibodies
Acute- usually in children, 2 weeks after infection with life threating purpura
Chronic- usually in women, runs a fluctuating course of bleeding, purpura, epistaxis (bleeding from the nose) and menorrhagia (heavy menstrual bleeding)

208
Q

Purpura

A

occurs when small blood vessels leak blood under the skin

209
Q

Immune Thrombocytopenia (ITP) management

A

Test- Increased megakaryocytes, antiplatelet often present
No treatment if mild
If symptomatic or very low platelet count- Prednisolone to induce and maintain remission
Platelet transfusion ineffective (except in surgery or life threating bleed) as antibodies destroy them too quickly

210
Q

Thrombotic Thrombocytopenia Purpura (TTP)

A

causes extensive clots (microscopic thromboses) to form in small blood vessels throughout the body (thrombotic microangiopathy).
Characterised by the presence in the plasma of large von Willebrand Factor (VWF) strings

211
Q

Thrombotic Thrombocytopenia Purpura (TTP)- incidence

A

Very rare
Characterised into acquired (idiopathic) and congenital (familial) and affects 4-6 people per million, affecting women more than men with a peak incidence in your forties

212
Q

Thrombotic Thrombocytopenia Purpura (TTP)- treatment

A

Acute- 1st line Plasma exchange + corticosteroid
Consider caplacizumab, aspirin, folic acid +/ transfusion
2nd line immunosuppression, 3rd line splenectomy
Long term- low dose aspirin

213
Q

Thrombotic Thrombocytopenia Purpura (TTP)- presentation

A

non-specific prodrome
severe neurological symptoms (coma, focal abnormalities, seizures)
mild neurological symptoms (headache, confusion)
fever

214
Q

Thrombotic Thrombocytopenia Purpura (TTP)- investigation

A

Degree of thrombocytopenia varies, but decreased platelets are required for the diagnosis of TTP
ADAMTS-13 (von Willebrand factor cleaving enzyme) activity levels of <5% to 10% are diagnostic.

Phase 2a Lecture Notes (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions